3B Medical Selects Vodafone To Deliver Sleep Data Wirelessly
WINTER HAVEN, Fla., Feb. 17, 2016 (GLOBE NEWSWIRE) -- More than one-quarter of the U.S. population report occasionally not getting enough sleep, while nearly 10 percent experience chronic insomnia[1]. Helping patients to more easily manage and treat sleep disorders, 3B Medical and BMC Medical (3B/BMC) have selected Vodafone to deliver a global mobile solution to the reporting of sleep efficacy and compliance data from their line of Luna CPAP (continuous positive airway pressure) devices, commonly used to treat sleep apnea, one of the most common sleep disorders.
The agreement will allow 3B Medical Luna devices that are pre-installed with a Vodafone global SIM to automatically upload sleep data to 3B’s cloud-based patient management system, iCodeConnect. Regardless of patient location, iCodeConnect provides secure, real-time clinician and physician access and management of patient records, compliance reports, and the ability to track overall treatment progress. Luna devices that are being used by patients who travel globally or by those who do not have existing WiFi connections in their home will now be able to realize the benefits of real-time data analysis and reporting.
"This new relationship with Vodafone is a significant next step in our wireless vision, which started with free wireless data connectivity using WiFi. The addition of mobile data significantly enhances our wireless functionality with a device that automatically uploads to the cloud everywhere and anywhere, even across international borders on Vodafone's global mobile network," said Joe Toth, Vice President of Sales and Marketing at 3B Medical. "Mobile data allows our devices to communicate with no patient involvement and makes sleep compliance reporting effortless.”
Vodafone Group’s Head of M2M Americas Andrew Morawski said, “3B Medical will be able to better manage and treat sleep disorder patients with access to information in real-time using the Vodafone global SIM running over our mobile network. 3B Medical is a great example of how the healthcare industry is embracing the power of IOT technology to the benefit of patients, providers and insurers.”
About Vodafone Machine-to-Machine (M2M)
Vodafone Machine-to-Machine (M2M) connects previously isolated machines or devices to the internet, delivering new functionality and enhanced services without the need for human intervention. Supported by more than 1,300 dedicated employees, Vodafone’s global M2M platform makes it easy for global businesses to manage centrally M2M deployments across multiple territories, with greater control and at a lower cost than previously possible. In 2015 Vodafone was named world’s best communications service provider for M2M by Analysys Mason, for the fourth year in a row. For more information, please visit: www.m2m.vodafone.com/home
About Vodafone Group
Vodafone is one of the world’s largest telecommunications companies and provides a range of services including voice, messaging, data and fixed communications. Vodafone has mobile operations in 26 countries, partners with mobile networks in 57 more, and fixed broadband operations in 17 markets. As of 31 December 2015, Vodafone had 461 million mobile customers and 13 million fixed broadband customers. For more information, please visit: www.vodafone.com.
About 3B/BMC: 3B/BMC is a global leader in the development, manufacturing and marketing of medical products for the treatment and management of sleep disordered breathing.
[1] “Division of Population Health,” National Center for Chronic Disease Prevention and Health Promotion, March 12, 2015
Contacts: For News Media Rebecca Velazquez | 3B Medical, Inc. 799 Overlook Drive, Winter Haven, FL 33884 Email: rvelazquez@3Bproducts.com Tel: (863) 226-6285 ext. 108 Vodafone Americas Media Relations: Melissa.salottolo@vodafone.com